
News|Videos|February 27, 2017
Dr Yehuda Handelsman Discusses New Alternatives to Basal Insulin
Recent advances in insulin formulations and innovative drug classes have made it easier than ever to manage diabetic patients’ glucose levels, according to Yehuda Handelsman, MD, FACP, FACE, FNLA, medical director and principal investigator at the Metabolic Institute of America.
Advertisement
Recent advances in insulin formulations and innovative drug classes have made it easier than ever to manage diabetic patients’ glucose levels, according to Yehuda Handelsman, MD, FACP, FACE, FNLA, medical director and principal investigator at the Metabolic Institute of America.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First-in-Class Optune Pax Device for Pancreatic Cancer
2
Contributor: American Patients vs Foreign Governments—A Tale of 2 Value Sets
3
Bipartisan Break Up Big Medicine Act Targets Vertical Integration in Health Care
4
3-Year EPCORE NHL-1 Data Published Showing 53% Have Deep, Durable Remission
5
















